EUDA Health to Launch EUDA Helixé 2.0 in January 2026

Core Insights - EUDA Health Holdings Limited is set to launch EUDA Helixé 2.0 in January 2026, representing a significant upgrade in its premium vitality and longevity supplement line [1][6] Product Enhancements - The new formulation includes a 20% increase in New Zealand sourced deer placenta powder, raising the dosage from 100 mg to 120 mg, enhancing its potency [2] - L-glutathione has been replaced with D-alpha-tocopherol (Vitamin E, 1.4 mg equivalent) to improve antioxidant stability and support skin health [2] - Advanced encapsulation technology has been implemented to enhance stability, absorption efficiency, and shelf life, utilizing a nano-based delivery system for smaller capsule sizes [3][8] Packaging and Design - A new proprietary bottle design has been introduced to reflect the premium positioning of EUDA Helixé, enhancing product protection and brand identity [4] Market Expansion - EUDA Helixé 2.0 has received New Zealand Halal certification, facilitating broader international distribution and entry into Muslim markets across Southeast Asia and the Middle East [5] Strategic Positioning - The launch of EUDA Helixé 2.0 underscores the company's commitment to innovation and global wellness solutions, positioning it as a core offering within EUDA's health and longevity ecosystem [6][7] - The company aims to address the healthcare needs of over 1.8 billion people in Asia, focusing on the growing longevity sector as populations age [9]